Brevan Howard Capital Management’s Erasca ERAS Stock Holding History

Brevan Howard Capital Management’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$829K	Sell	45,235 -9,869	-18%	-$141K	0.01%	1165
2026 Q1	$892K	Buy	55,104 +2,373	+5%	+$28K	0.01%	969
2025 Q4	$196K	Sell	52,731 -38,015	-42%	-$107K	﹤0.01%	1585
2025 Q3	$198K	Sell	90,746 -31,925	-26%	-$50.8K	﹤0.01%	1757
2025 Q2	$156K	Buy	+122,671	New	+$164K	﹤0.01%	1753
2025 Q1	–	Sell	-16,158	Closed	-$40.6K	–	1250
2024 Q4	$40.6K	Buy	+16,158	New	+$44.3K	﹤0.01%	990
2024 Q2	–	Sell	-18,638	Closed	-$38.4K	–	1144
2024 Q1	$38.4K	Buy	+18,638	New	+$37.3K	﹤0.01%	949

Other funds holding ERAS

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Brevan Howard Capital Management's ERAS Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Erasca (ERAS) stake by 18% in Q2 2026, selling an estimated $141K and leaving 45,235 shares worth $829K. The position accounts for 0.01% of the portfolio, ranked #1165.

Brevan Howard Capital Management first reported a position in ERAS in Q1 2024 and has held it in 7 quarters since. The position peaked at $892K in Q1 2026. 256 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

Brevan Howard Capital Management held 45,235 shares of Erasca worth $829K as of Q2 2026.
Brevan Howard Capital Management sold 9,869 Erasca shares in Q2 2026, an estimated $141K.
Erasca made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1165 holding.
Brevan Howard Capital Management first reported a position in Erasca in Q1 2024 and has held it in 7 quarters since.
Brevan Howard Capital Management's Erasca position peaked at $892K in Q1 2026.
256 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.